- $4.20m
- $7.69m
- $5.05m
- 32
- 51
- 17
- 25
Annual cashflow statement for Stemtech, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 August 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 15 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -0.034 | -7.11 | -8.63 | -5.43 | -3.77 |
| Depreciation | |||||
| Amortisation | |||||
| Non-Cash Items | 0.015 | 3.79 | 7.3 | 1.72 | 1.45 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -0.048 | 0.973 | -0.336 | 1.09 | 1.38 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Payable / Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -0.066 | -1.91 | -1.22 | -2.04 | -0.601 |
| Capital Expenditures | 0 | — | — | — | 0 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | — | 0 | — | — | — |
| Sale of Fixed Assets | |||||
| Cash from Investing Activities | 0 | 0 | — | — | 0 |
| Financing Cash Flow Items | — | 0 | — | — | — |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 0.068 | 2.63 | 0.339 | 1.58 | 1.08 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 0.002 | 0.695 | -0.696 | -0.018 | 0.141 |